These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 7662688

  • 1. Depo-Provera in adolescents: effects of early second injection or prior oral contraception.
    Harel Z, Biro FM, Kollar LM.
    J Adolesc Health; 1995 May; 16(5):379-84. PubMed ID: 7662688
    [Abstract] [Full Text] [Related]

  • 2. Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant.
    Harel Z, Biro FM, Kollar LM, Rauh JL.
    J Adolesc Health; 1996 Aug; 19(2):118-23. PubMed ID: 8863083
    [Abstract] [Full Text] [Related]

  • 3. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception.
    Cromer BA, Smith RD, Blair JM, Dwyer J, Brown RT.
    Pediatrics; 1994 Nov; 94(5):687-94. PubMed ID: 7936897
    [Abstract] [Full Text] [Related]

  • 4. Depo Provera. Position paper on clinical use, effectiveness and side effects.
    Bigrigg A, Evans M, Gbolade B, Newton J, Pollard L, Szarewski A, Thomas C, Walling M.
    Br J Fam Plann; 1999 Jul; 25(2):69-76. PubMed ID: 10454658
    [Abstract] [Full Text] [Related]

  • 5. Teens and Depo-Provera: a good match?
    Contracept Technol Update; 1995 Jul; 16(7):86-8. PubMed ID: 12346507
    [Abstract] [Full Text] [Related]

  • 6. Depo-Provera use in an Australian metropolitan practice.
    Fraser IS, Dennerstein GJ.
    Med J Aust; 1994 May 02; 160(9):553-6. PubMed ID: 8164553
    [Abstract] [Full Text] [Related]

  • 7. Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents.
    Polaneczky M, Liblanc M.
    J Adolesc Health; 1998 Aug 02; 23(2):81-8. PubMed ID: 9714170
    [Abstract] [Full Text] [Related]

  • 8. Long-term contraception with Depo-Provera: a clinical evaluation.
    Mukherjea M, Mukherjee P, Biswas R.
    Int J Fertil; 1980 Aug 02; 25(2):122-6. PubMed ID: 6117526
    [Abstract] [Full Text] [Related]

  • 9. Depo-provera: clinical evaluation.
    Mukherjea M.
    Contracept Deliv Syst; 1981 Jul 02; 2(3):259-69. PubMed ID: 12278913
    [Abstract] [Full Text] [Related]

  • 10. Contraception in the adolescent patient.
    Tafelski T, Boehm KE.
    Prim Care; 1995 Mar 02; 22(1):145-59. PubMed ID: 7777635
    [Abstract] [Full Text] [Related]

  • 11. Early experience with the contraceptive use of depot medroxyprogesterone acetate in an inner-city clinic population.
    Polaneczky M, Guarnaccia M, Alon J, Wiley J.
    Fam Plann Perspect; 1996 Mar 02; 28(4):174-8. PubMed ID: 8853283
    [Abstract] [Full Text] [Related]

  • 12. Acceptability study of the two versus three monthly injectable contraceptives.
    Aly FA, El-genedi MM, Toppozada HK, El-abd M, Loutfi I.
    Dirasat Sukkaniyah; 1984 Mar 02; 11(69):27-39. PubMed ID: 12179796
    [Abstract] [Full Text] [Related]

  • 13. Adolescents' experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra.
    Harel Z, Riggs S, Vaz R, Flanagan P, Dunn K, Harel D.
    J Pediatr Adolesc Gynecol; 2005 Apr 02; 18(2):85-90. PubMed ID: 15897103
    [Abstract] [Full Text] [Related]

  • 14. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
    Cromer BA, Blair JM, Mahan JD, Zibners L, Naumovski Z.
    J Pediatr; 1996 Nov 02; 129(5):671-6. PubMed ID: 8917232
    [Abstract] [Full Text] [Related]

  • 15. Supplementation with vitamin C and/or vitamin B(6) in the prevention of Depo-Provera side effects in adolescents.
    Harel Z, Biro F, Kollar L, Riggs S, Flanagan P, Vaz R.
    J Pediatr Adolesc Gynecol; 2002 Jun 02; 15(3):153-8. PubMed ID: 12106752
    [Abstract] [Full Text] [Related]

  • 16. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Mainwaring R, Hales HA, Stevenson K, Hatasaka HH, Poulson AM, Jones KP, Peterson CM.
    Contraception; 1995 Mar 02; 51(3):149-53. PubMed ID: 7621683
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and acceptability of depo-medroxyprogesterone acetate injection. As a method of contraception in Saudi Arabia.
    Sobande AA, Al-Bar HM, Archibong EI, Sadek AA.
    Saudi Med J; 2000 Apr 02; 21(4):348-51. PubMed ID: 11533816
    [Abstract] [Full Text] [Related]

  • 18. A comparative study of one-year weight gain among users of medroxyprogesterone acetate, levonorgestrel implants, and oral contraceptives.
    Moore LL, Valuck R, McDougall C, Fink W.
    Contraception; 1995 Oct 02; 52(4):215-9. PubMed ID: 8605778
    [Abstract] [Full Text] [Related]

  • 19. Acceptability and discontinuation of Depo-Provera, IUCD and combined pill in Kenya.
    Sekadde-Kigondu C, Mwathe EG, Ruminjo JK, Nichols D, Katz K, Jessencky K, Liku J.
    East Afr Med J; 1996 Dec 02; 73(12):786-94. PubMed ID: 9103686
    [Abstract] [Full Text] [Related]

  • 20. Adolescent satisfaction with postpartum contraception and body weight concerns.
    Hellerstedt WL, Story M.
    J Adolesc Health; 1998 Jun 02; 22(6):446-52. PubMed ID: 9627814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.